---
figid: PMC5677022__41598_2017_12259_Fig3_HTML
figlink: /pmc/articles/PMC5677022/figure/Fig3/
number: F3
caption: The 10-miRNA-score predicts defects in the HR pathway in ovarian cancer.
  (A) The genomic alterations in HR pathway related genes between the high 10-miRNA-score
  (green) and low 10-miRNA-score (red) groups in ovarian cancer. (B) Frequency of
  HR defects. The left panel shows the frequency of HR genes in the high 10-miRNA-score
  group compared with that in the low 10-miRNA-score group. The right panel shows
  the number of tumours with amplification of EMSY or copy number loss of PTEN in
  the high 10-miRNA-score and low 10-miRNA-score groups. (C,D and E) Alterations of
  the PI3K/RAS (C), RB (D) and FOXM1 (E) signalling pathways that are commonly altered
  in ovarian cancer. Alterations are defined by somatic mutations, amplifications
  and up- or downregulated gene expressions. The background colour of each node represents
  activation (light blue) or inactivation (light red). The percentages of alteration
  are in green frames for the low 10-miRNA-score group or in red frames for the high
  10-miRNA-score group.
pmcid: PMC5677022
papertitle: The expression of miRNAs is associated with tumour genome instability
  and predicts the outcome of ovarian cancer patients treated with platinum agents.
reftext: Tianzhen Wang, et al. Sci Rep. 2017;7:14736.
pmc_ranked_result_index: '19022'
pathway_score: 0.7870834
filename: 41598_2017_12259_Fig3_HTML.jpg
figtitle: 10-miRNA-score predicts defects in the HR pathway in ovarian cancer
year: '2017'
organisms: Homo sapiens
ndex: 7493ff6f-de99-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5677022__41598_2017_12259_Fig3_HTML.html
  '@type': Dataset
  description: The 10-miRNA-score predicts defects in the HR pathway in ovarian cancer.
    (A) The genomic alterations in HR pathway related genes between the high 10-miRNA-score
    (green) and low 10-miRNA-score (red) groups in ovarian cancer. (B) Frequency of
    HR defects. The left panel shows the frequency of HR genes in the high 10-miRNA-score
    group compared with that in the low 10-miRNA-score group. The right panel shows
    the number of tumours with amplification of EMSY or copy number loss of PTEN in
    the high 10-miRNA-score and low 10-miRNA-score groups. (C,D and E) Alterations
    of the PI3K/RAS (C), RB (D) and FOXM1 (E) signalling pathways that are commonly
    altered in ovarian cancer. Alterations are defined by somatic mutations, amplifications
    and up- or downregulated gene expressions. The background colour of each node
    represents activation (light blue) or inactivation (light red). The percentages
    of alteration are in green frames for the low 10-miRNA-score group or in red frames
    for the high 10-miRNA-score group.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXM1
  - PIK3CA
  - BIRC5
  - PLK1
  - BRAF
  - BRCA1
  - BRCA2
  - AURKB
  - PTEN
  - CHEK2
  - HRAS
  - NRAS
  - KRAS
  - PIK3R6
  - RAD51
  - AKT1
  - MUT
  - CCNB1
  - MFAP1
  - EMSY
  - FANCD2
  - PIK3R3
  - NF1
  - CCND1
  - RB1
  - AKT2
  - CDKN2A
  - CCND2
  - ATR
  - PIK3CG
  - CDC25B
  - ATM
  - TP53
  - CCNE1
  - PIK3R5
  - PIK3CB
  - PIK3CD
  - PIK3R4
  - Breast cancer
  - Cancer
  - Lung cancer
  - Melanoma
genes:
- word: FOXM1
  symbol: FOXM1
  source: hgnc_symbol
  hgnc_symbol: FOXM1
  entrez: '2305'
- word: PIK3CA
  symbol: PIK3CA
  source: hgnc_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: BIRC5
  symbol: BIRC5
  source: hgnc_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: PLK1
  symbol: PLK1
  source: hgnc_symbol
  hgnc_symbol: PLK1
  entrez: '5347'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: BRCA1
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: BRCA2
  symbol: BRCA2
  source: hgnc_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: AURKB
  symbol: AURKB
  source: hgnc_symbol
  hgnc_symbol: AURKB
  entrez: '9212'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CHEK2
  symbol: CHEK2
  source: hgnc_symbol
  hgnc_symbol: CHEK2
  entrez: '11200'
- word: PI3K/RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K/RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K/RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAD51
  symbol: RAD51
  source: hgnc_symbol
  hgnc_symbol: RAD51
  entrez: '5888'
- word: AKT1
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: mut.
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: CCNB1
  symbol: CCNB1
  source: hgnc_symbol
  hgnc_symbol: CCNB1
  entrez: '891'
- word: amp
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: EMSY
  symbol: EMSY
  source: hgnc_symbol
  hgnc_symbol: EMSY
  entrez: '56946'
- word: FANCD2
  symbol: FANCD2
  source: hgnc_symbol
  hgnc_symbol: FANCD2
  entrez: '2177'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RB1
  symbol: RB1
  source: hgnc_symbol
  hgnc_symbol: RB1
  entrez: '5925'
- word: AKT2
  symbol: AKT2
  source: hgnc_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CDKN2A
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: CCND2
  symbol: CCND2
  source: hgnc_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CDC25B
  symbol: CDC25B
  source: hgnc_symbol
  hgnc_symbol: CDC25B
  entrez: '994'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: CCNE1
  symbol: CCNE1
  source: hgnc_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/RAS
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals: []
diseases:
- word: Breast cancer
  source: ''
  identifier: ''
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
figid_alias: PMC5677022__F3
redirect_from: /figures/PMC5677022__F3
figtype: Figure
---
